Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran

被引:46
|
作者
Sohrabi, Nasrollah [2 ,3 ]
Farajnia, Safar [1 ,4 ]
Akhi, Mohammad Taghi [3 ]
Nahaei, Mohammad Reza [3 ]
Naghili, Behrooz [2 ]
Peymani, Amir [5 ]
Amiri, Zohreh [6 ]
Rezaee, Mohammad Ahangarzadeh [3 ]
Saeedi, Nazli [4 ]
机构
[1] Tabriz Univ Med Sci, Biotechnol Res Ctr, Mol Biol Lab, Tabriz 5165665811, Iran
[2] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz 5165665811, Iran
[3] Tabriz Univ Med Sci, Dept Microbiol, Tabriz 5165665811, Iran
[4] Tabriz Univ Med Sci, TB & Lung Dis Res Ctr, Tabriz 5165665811, Iran
[5] Qazvin Univ Med Sci, Dept Microbiol, Qazvin, Iran
[6] Razi Univ, Fac Sci, Dept Biol, Kermanshah, Iran
关键词
CARBAPENEM RESISTANCE; MOLECULAR EPIDEMIOLOGY; DISSEMINATION; MECHANISMS; STRAINS; GENES;
D O I
10.1089/mdr.2011.0077
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Carbapenems have been considered as last line antibiotics for treatment of multidrug-resistant (MDR) Acinetobacter baumannii but carbapenem resistant A. baumannii has been increased during the last decade in many parts of the world. OXA-type beta-lactamase enzymes are the most common cause of carbapenem resistance in A. baumannii and presence of ISAba1 in upstream of these genes may increase the expression of these OXA genes. The aim of this study was to determine, for the first time, the antibiotic resistance pattern and prevalence of OXA type beta-lactamases among nosocomial A. baumannii isolates from northwest of Iran. A total of 100 A. baumannii isolates were recovered from hospitalized patients in a university hospital in northwest of Iran. Sixty-two percent of isolates were resistant to imipenem. All isolates carried bla(OXA-51)-like gene. Among imipenem resistant isolates, 88.7% carried bla(OXA-23)-like, 1.6% carried bla(OXA-40)-like, and 3.2% had bla(OXA-58)-like resistance genes. Ninety percent of isolates contained ISAba1 element and in 74.2% of imipenem resistant isolates, ISAba1 was located in upstream of bla(OXA-23)-like. The results of this study demonstrated high prevalence of OXA-type carbapenemase among MDR A. bumanii in the Northwest of Iran.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 50 条
  • [21] First report of SPM metallo-β-lactamases producing Acinetobacter baumannii isolates in Morocco
    Massik, Abdelhamid
    Hibaoui, Lahbib
    Moussa, Benboubker
    Yahyaoui, Chita
    Oumokhtar, Bouchra
    Mahmoud, Mustapha
    IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (04) : 438 - 444
  • [22] Distribution of OXA-Type Class D β-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals
    Karmostaji, Afsaneh
    Peerayeh, Shahin Najar
    Salmanian, Ali Hatef
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2013, 6 (05)
  • [23] Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea
    Lee, Kyungwon
    Kim, Mi-Na
    Choi, Tae Yeal
    Cho, Soung-Eun
    Lee, Seungok
    Whang, Dong Hee
    Yong, Dongeun
    Chong, Yunsop
    Woodford, Neil
    Livermore, David M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (06) : 520 - 524
  • [24] Prevalence of Ambler class A β-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii
    Rezaee, Mohammad Ahangarzadeh
    Pajand, Omid
    Nahaei, Mohammad Reza
    Mahdian, Reza
    Aghazadeh, Mohammad
    Ghojazadeh, Morteza
    Hojabri, Zoya
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (03) : 330 - 334
  • [25] Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
    Lindgren, Patricia Komp
    Higgins, Paul G.
    Seifert, Harald
    Cars, Otto
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 661 - 665
  • [26] Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
    Aliakbarzade, Katayun
    Farajnia, Safar
    Nik, Ashraf Karimi
    Zarei, Farzaneh
    Tanomand, Asghar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (10)
  • [27] Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
    Rumbo, C.
    Gato, E.
    Lopez, M.
    Ruiz de Alegria, C.
    Fernandez-Cuenca, F.
    Martinez-Martinez, L.
    Vila, J.
    Pachon, J.
    Cisneros, J. M.
    Rodriguez-Bano, J.
    Pascual, A.
    Bou, G.
    Tomas, M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5247 - 5257
  • [28] OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq
    Ganjo, Aryann R.
    Maghdid, Delshad M.
    Mansoor, Isam Y.
    Kok, Dik J.
    Severin, Juliette A.
    Verbrugh, Henri A.
    Kreft, Deborah
    Fatah, M. H.
    Alnakshabandi, A. A.
    Dlnya, Asad
    Hammerum, Anette M.
    Ng, Kim
    Goessens, Wil
    MICROBIAL DRUG RESISTANCE, 2016, 22 (08) : 627 - 637
  • [29] Prevalence of Aminoglycoside and Carbapenemase Resistance Genes and Biofilm Formation among Clinical Isolates of Acinetobacter baumannii in Iran
    Ghasemi, Saba
    Shoja, Saeed
    Mazloomirad, Farzad
    Ghatee, Mohammad Amin
    Rashidpoor, Fatemeh
    Khoramrooz, Seyed Sajjad
    Khosravani, Seyed Abdolmajid
    Sharifi, Asghar
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [30] Prevalence and Mechanisms of Carbapenem Resistance Among Acinetobacter baumannii Clinical Isolates in Egypt
    Benmahmod, Abdalbagi Basheer
    Said, Heba Shehta
    Ibrahim, Ramdan Hassan
    MICROBIAL DRUG RESISTANCE, 2019, 25 (04) : 480 - 488